Limpid Markets
← Back to Intelligence

Cellectar Biosciences stock soars 130% on $140M financing

Investing.com Gold Tier 2 2026-05-05 11:07 UTC 📖 1 min read Neutral

Investing.com Gold reports: Cellectar Biosciences stock soars 130% on $140M financing. Full body text was unavailable at ingest time, so this brief is based on headline context.

↗ Read Original